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examine essentiality of pteridine reductase (PTR1) in
pterin metabolism in the African trypanosome.
Attempts to generate PTR1 null mutants in blood-
stream form Trypanosoma brucei proved unsuccess-
ful; despite integration of drug selectable markers at
the target locus, the gene for PTR1 was either retained
at the same locus or elsewhere in the genome.
However, RNA interference (RNAi) resulted in com-
plete knockdown of endogenous protein after 48 h,
followed by cell death after 4 days. This lethal pheno-
type was reversed by expression of enzymatically
active Leishmania major PTR1 in RNAi lines (oeRNAi)
or by addition of tetrahydrobiopterin to cultures. Loss
of PTR1 was associated with gross morphological
changes due to a defect in cytokinesis, resulting in
cells with multiple nuclei and kinetoplasts, as well as
multiple detached ﬂagella. Electron microscopy also
revealed increased numbers of glycosomes, while
immunoﬂuorescence microscopy showed increased
and more diffuse staining for glycosomal matrix
enzymes, indicative of mis-localisation to the cytosol.
Mis-localisation was conﬁrmed by digitonin fraction-
ation experiments. RNAi cell lines were markedly less
virulent than wild-type parasites in mice and virulence
was restored in the oeRNAi line. Thus, PTR1 may be a
drug target for human African trypanosomiasis.
Introduction
Tetrahydrobiopterin (H4B) is an essential cofactor for
various hydroxylation reactions catalysed by enzymes
such as aromatic amino acid hydroxylases, glyceryl ether
monooxygenases and NO synthases (Thony et al., 2000;
Werner-Felmayer et al., 2002; Schmidt and Alp, 2007;
Watschinger et al., 2009). In humans, H4B can be synthe-
sized de novo from GTP or salvaged from dihydrobiop-
terin (H2B) via NADPH-dependent dihydrofolate
reductase (DHFR, EC 1.5.13) (Nichol et al., 1983) or
regenerated from quinonoid dihydrobiopterin, a by-
product of hydroxylation reactions, via NAD(P)H-
dependent 6,7-dihydropteridine reductase (DHPR; EC
1.5.1.34) (Armarego et al., 1983).
In contrast to humans, biological and genomic data
indicate that trypanosomatids lack the ability to synthesize
pterins de novo, and are totally dependent on salvage of
extracellular pterins for growth (Bello et al., 1994; Cun-
ningham and Beverley, 2001; Berriman et al., 2005; Ivens
et al., 2005). The essential requirement for pterins was
initially discovered in Crithidia fasciculata grown in a
deﬁned medium containing low amounts of folate (Kidder
and Dutta, 1958; Kaufman, 1963); and our subsequent
understanding of the uptake, salvage and functions of
pterins in trypanosomatids has come principally from
studies by the Beverley and Ouellette groups (Nare et al.,
1997; Ouellette et al., 2002). In Leishmania spp., biopterin
is taken up from the medium via the biopterin transporter
BT1 (Kundig et al., 1999; Lemley et al., 1999) and then
sequentially reduced to H2B and H4B by pteridine reduc-
tase 1 (PTR1; EC 1.5.1.33) (Bello et al., 1994). Previous
studies on Leishmania ptr1 - mutants suggested the pres-
ence of a residual pteridine reductase activity, provision-
ally assigned as PTR2. This activity is considered not to
be due to quinonoid dihydropteridine reductase and the
identity of PTR2 remains unknown (Lye et al., 2002).
Some kinetic, inhibitor and structural properties have
been reported for PTR1 from Leishmania major (Luba
et al., 1998; Gourley et al., 2001; Schuttelkopf et al.,
2005), Trypanosoma cruzi (Schormann et al., 2005) and
Trypanosoma brucei (Dawson et al., 2006; Mpamhanga
et al., 2009; Shanks et al., 2010). Gene knockout studies
in L. major have demonstrated that PTR1 is essential for
growth of the insect promastigote stage of the parasite,
where growth of ptr1 - null mutants could be restored with
H2Bo rH 4B, but not by dihydro- or tetrahydrofolate (Bello
et al., 1994). These mutants showed increased formation
of mammalian-infective metacyclic promastigote forms in
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© 2010 Blackwell Publishing Ltdstationary phase cultures and consequently gave larger
lesions when injected into mice (Cunningham et al.,
2001). This indicates that ptr1 - amastigotes are viable in
vivo, presumably due to abundant H4B in host macroph-
ages and consequently that PTR1 is not a drug target on
its own in L. major.
PTR1 has a secondary role in metabolism in being able
to reduce dihydrofolate to tetrahydrofolate. Ampliﬁcation
of PTR1 in Leishmania spp. is one of the several mecha-
nisms by which parasites acquire resistance to antifolates
such as methotrexate (Callahan and Beverley, 1992;
Papadopoulou et al., 1992; Bello et al., 1994) either by
acting as a by-pass mechanism or by sequestering these
DHFR inhibitors. Recent studies have demonstrated an
intriguing link between unconjugated pterins and oxidative
susceptibility in a variety of Leishmania PTR1 knockout
and overexpressing cell lines (Moreira et al., 2009; Nare
et al., 2009). However, the mechanism involved is not
clear; neither is it known whether pterins have additional
essential functions in these parasites.
In contrast to Leishmania spp. virtually nothing is known
about pterin metabolism in African trypanosomes, para-
sitesthatoccupyacompletelydifferent(extracellular)envi-
ronment in the mammalian host. In this study we use
genetic methods to examine the role of PTR1 in blood
stream form T. brucei with respect to essentiality in vitro
and infectivity in vivo. Our ﬁndings suggest that reduced
pterinsarerequiredforglycosomeandﬂagellarbiogenesis
and that loss of PTR1 activity cannot be compensated for
byreducedpterinsinplasmaandextracellularﬂuids.Thus,
unlike L. major, PTR1 is a potential drug target in the
African trypanosome without reference to DHFR.
Results
Genotypic and phenotypic analysis of TbPTR1
knockdown in parasites
To assess the essentiality of PTR1, classical gene
replacement methods were undertaken to try to produce a
PTR1 null cell line of bloodstream trypanosomes. Consis-
tent with genome sequence data for strain 927 (Berriman
et al., 2005), Southern blot analysis conﬁrmed that PTR1
is single copy per haploid genome in the ‘single marker’
bloodstream T. brucei 427 used in these studies (data not
shown). This organism, subsequently referred to as wild-
type (WT), constitutively expresses T7 RNA polymerase
and the tetracycline repressor protein, and can be used to
express other RNA constructs under the control of tetra-
cycline (Wirtz et al., 1999). Replacement of one copy of
PTR1 to generate a single knockout (SKO) could be
readily achieved by transfection with a construct contain-
ing a drug resistance gene (either HYG or PAC) ﬂanked
by the 5′- and 3′-untranslated regions of PTR1, followed
by drug selection with either hygromycin or puromycin,
essentially as described (Sienkiewicz et al., 2008). SKO
lines (PTR1/ptr1::HYG [SKOHYG]o rPTR1/ptr1::PAC
[SKOPAC]) were then subjected to a second round of trans-
fection with the other knockout construct and selected for
resistance to both drugs. Despite obtaining double drug-
resistant trypanosomes in numerous independent experi-
ments, we were unable to obtain clones in which both
copies of PTR1 had been deleted. Southern blotting con-
ﬁrmed that integration of the drug-resistant genes had
indeed occurred at the correct locus, but was associated
with retention of an additional copy of PTR1 either at the
same locus or elsewhere in the genome (see Fig. S1). In
virulent strains of leishmania, such behaviour is typical of
an essential gene (Cruz et al., 1993), but has not been
reported for the African trypanosome. However, an
increase in chromosomal copy number has been reported
for trypanosomes selected for resistance to mycophenolic
acid, an inhibitor of IMP dehydrogenase (Wilson et al.,
1994). Attempts to generate conditional double knockout
cell lines by introducing an ectopic copy of PTR1
(pLew100_TbPTR1) under tetracycline control were also
unsuccessful.
In the light of these results, inducible RNA interference
(RNAi) studies using the p2T7TiTAblue system were
undertaken to deplete cells of PTR1 (Alibu et al., 2005).
For the disruption of PTR1 function, a 403 bp region was
ligated into the p2T7TiTAblue vector and a linearized con-
struct transfected into WT cells by electroporation. Cells
that had integrated the construct into the rDNA loci by
homologous recombination were obtained by selection
with hygromycin and then cloned. Generation of the
correct RNAi clones was conﬁrmed by Southern analysis
(data not shown), then tetracycline was added to cell
cultures to initiate the expression of PTR1-speciﬁc
double-stranded RNA. The average cumulative growth
with four different freshly derived clones is illustrated in
Fig. 1A. In the absence of inducer these cells grew at
essentially the same rate as WT cells. However, following
induction of PTR1 dsRNA, growth ceased after 1 day,
followed by a decline in cell numbers such that no motile
parasites were visible after 4 days. Levels of PTR1 protein
were diminished compared with WT in non-induced RNAi
lines (Fig. 1A, inset) compared with the immunoglobulin
heavy-chain-binding protein (BiP) used as a loading
control. Densitometry of the PTR1 band relative to the BiP
control band indicated that the non-induced RNAi line had
50% of WT protein levels; this decreased further to 9%
24 h after RNAi induction and was not detectable
after 48 h. This RNAi phenotype was unstable; if the
tetracycline-induction was repeated after a further 2–3
weeks in culture, cells either showed no growth defect
with no knockdown of PTR1, or brief cytostasis followed
by normal growth (Fig. S2). To conﬁrm that the cidal effect
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supplementation with H4B was examined on a freshly
derived clone (Fig. 1B). Addition of 10 mMH 4Bt oR N A i -
induced cultures abolished the lethal growth phenotype.
Additional evidence of the essential requirement for
PTR1 activity was obtained by introducing an inducible
overexpressing ectopic copy of L. major PTR1 into the
WT line (oeWT) prior to generation of TbPTR1 RNAi lines
(oeRNAi). Due to the high GC content of the L. major gene,
the sequence identity with the T. brucei RNAi construct is
less than 50%, with no more than 13 nucleotide stretches
of identity. Thus, LmPTR1 mRNA should not be suscep-
tible to degradation, since assembly of an RNA-induced
silencing complex requires formation of 20–26-mer
double-stranded RNA(Ullu et al., 2004). Indeed, following
tetracycline induction, oeRNAi cells showed no sign of any
growth defect whatsoever (Fig. 2A). Western blotting with
antisera raised against recombinant T. brucei PTR1
showed that TbPTR1 expression is undetectable follow-
ing induction (Fig. 2B; TbPTR1 is ~30 kDa and the 55 kDa
cross-reacting band serves as an internal loading control).
In contrast, Western blotting with a second antiserum
Fig. 1. The effect of RNAi-dependent depletion of PTR1 on growth in the presence or absence of tetrahydrobiopterin.
A. Effect of RNAi on cell growth. Four independent RNAi clones were analysed for growth defects following induction with tetracycline in the
absence of tetrahydrobiopterin. WT (open circles) and RNAi cells (non-induced cells – open squares and induced cells – closed squares) were
seeded at 1 ¥ 10
4 cells ml
-1 and growth was determined over a 2 week period. WT, non-induced and induced cells (1 ¥ 10
6 cells per lane)
were harvested at 0 (non-induced), 24 h and 48 h (induced) and processed for Western blot analysis. The blot was sequentially probed with
anti-TbPTR1 (inset, lower panel) and anti-TbBIP (inset, upper panel) as loading control.
B. Effect of tetrahydrobiopterin on cell growth. WT cells and a freshly derived RNAi clone were seeded into FDM or HMI9-T supplemented
with or without 10 mM tetrahydrobiopterin at 1 ¥ 10
4 cells ml
-1 and growth monitored over 1 week. Symbols: WT (open circle; no additions),
non-induced RNAi cells (closed circles) and tetracycline-induced cells plus or minus tetrahydrobiopterin (closed and open squares
respectively). Data shown for FDM only; HMI9-T shows essentially the same effect.
Fig. 2. Rescue of RNAi growth defect by
expression of LmPTR1.
A. Cumulative growth of WT (open circles)
non-induced




B. Western blot analysis demonstrating
knockdown of TbPTR1 in
oeRNAi cells.
Non-induced (-) and 48 h tetracycline induced
(+) cells were probed sequentially with
anti-TbPTR1 and anti-LmPTR1. A 55 kDa
non-speciﬁc band was detected with
anti-TbPTR1, which was not effect by the
knockdown of PTR1 and serves as an internal
loading control (top panel), while LmPTR1 is
present in both (bottom panel).
660 N. Sienkiewicz, H. B. Ong and A. H. Fairlamb 
© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 658–671speciﬁc to L. major PTR1 shows the opposite effect.
LmPTR1 is visible as a ~30 kDa band in non-induced
(due to leaky nature of the promoter in pLew82) which
increases following induction. PTR1 activity was mea-
sured in cell lysates to validate these results. As shown in
Fig. 3, PTR1 activity is proportional to protein concentra-
tion for each cell line. WT cells have a speciﬁc activity of
22.9  1.9 nmol min mg-1 and this is decreased to
8.0  0.2 nmol min mg-1 in the SKO line, whereas this
increases by 2.5- and 10-fold in RNAlines overexpressing
LmPTR1 in the absence or presence of inducer
(58.1  9.3 and 231  19 nmol min mg-1 respectively).
These results demonstrate that LmPTR1 is enzymatically
active when expressed in T. brucei and is able to rescue
the lethal RNAi phenotype.
Infectivity studies were undertaken in mice to examine
the virulence of RNAi and oeRNAi transgenic
trypanosomes. Wild-type and non-induced transgenic
cells were inoculated into paired groups of mice, where
one pair received doxycycline in their drinking water.
Parasitaemia was monitored at intervals for 30 days;
animals achieving a parasitaemia greater than 108 trypa-
nosomes per millilitre were euthanized as previous
studies had established that these levels were consis-
tently lethal within the next 24 h. Mice infected with 105
WT cells were unable to survive longer than 3–4 days
(Fig. 4), whereas mice infected with RNAi cells survived
for much longer regardless of doxycycline treatment. The
reduced virulence observed in the minus doxycycline
group was probably due to leaky transcription of the p2T7
promoter, which lowers the baseline expression of PTR1
(Fig. 1A) and in some instances is associated with an
initial lag in growth compared with WT (Fig. 1B). Six out of
10 mice treated with doxycycline failed to develop a para-
sitaemia and survived beyond 30 days. Infection with
oeRNAi cells (with or without doxycycline) restored the
virulence phenotype to that of WT cells.
Morphological changes associated with PTR1 depletion
Severe morphological abnormalities could be observed in
bloodstream trypanosomes by light and electron micros-
copy prior to cell death. After induction of RNAi for
24–48 h, cells showed reduced motility, with some fatten-
ing of the cell body and shortening of the ﬂagellum com-
pared with the control (non-induced) samples. After 72 h,
Giemsa-stained preparations showed gross distension of
the cell body with multiple nuclei, kinetoplasts and
ﬂagella.
To provide an insight into any changes in the cell cycle
progression, DAPI-stained cells were analysed to deter-
mine the proportion of cells with one or more nucleus (N)
and kinetoplast (K) from control, non-induced and
tetracycline induced populations (Fig. 5). Non-induced
samples were predominately 1K1N (92%), whereas tetra-
cycline induction caused a dramatic time-dependent
Fig. 3. PTR1 enzyme activity in WT and transgenic T. brucei.
Cell lysates were assayed for PTR1 activity at various protein
concentrations as described in the materials and methods. WT,
open circles; SKO, closed circles;
oeRNAi minus tetracycline, open
squares;
oeRNAi plus tetracycline, closed squares.
Fig. 4. Virulence phenotype of PTR1 mutants in mice. Groups of
ﬁve mice were infected with WT, non-induced cells for RNAi and
oeRNAi cells and parasitaemia monitored at intervals over a 30 day
period. The Kaplan-Meier survival graph shows the aggregated
results of two independent experiments. Symbols: WT infection, no
doxycycline (black dashed line); RNAi infection, no doxycycline
(blue solid line); RNAi infection plus doxycycline (red solid line);
oeRNAi infection, no doxycycline (red dashed line);
oeRNAi infection
with doxycycline (black dashed line, identical to WT infection).
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72 h) with a corresponding increase in cells containing
either multiple kinetoplasts plus multiple nuclei (MKMN) or
anucleated zoids (1K0N). The number of cells with two
kinetoplasts and one nucleus (2K1N) increased threefold
from 6% to 19% by 48 h after induction, decreasing to 8%
at 72 h. 2K2N did not vary markedly throughout the
time course. These results suggest that most cells can
undergo several rounds of mitosis, but not cytokinesis.
Ultra-structural and surface alterations were examined
by transmission electron microscopy (TEM) and scanning
electron microscopy (SEM) (Fig. 6). The most obvious
aberrant feature present in the TEM sections of the RNAi-
induced cells is the increased number of membrane
bound electron-dense bodies (Fig. 6B and C) compared
with the non-induced control (Fig. 6A). These round,
sometimes sausage-shaped (Fig. 6C, inset) bodies are
morphologically similar to glycosomes, an organelle
related to peroxisomes (Opperdoes et al., 1984). Another
distinct feature in these treated cells is the increased
number of ﬂagella present in the 72 h sections
(Fig. 6B–E, arrowheads). Even though there are an aber-
rant number of ﬂagella associated with the main body of
the parasite, they appear to have the normal 9 + 2
arrangement of the microtubules of the axoneme and
paraﬂagellar rod, suggesting that the structural organisa-
tion of the ﬂagellum is unaffected by PTR1 depletion.
Some sections also appear to have more than one ﬂagel-
lar pocket (Fig. 6B), as well as a number of autophagic
vacuoles. Lastly, structures were evident in some sec-
tions, which appeared to be an internal non-membrane
bound ﬂagellum (Fig. 6B plus inset, starred), a phenotype
previously observed in the knockdown of VSG (Sheader
et al., 2005). Compared with a normal trypanosome
(Fig. 6D, inset), tetracycline-induced trypanosomes show
an increase in body size with some having sections of
ﬂagella detached from the body and lacking the undulat-
ing membrane (Fig. 6D, arrowheads). Multiple entangled
ﬂagella can be clearly identiﬁed in the SEM and DAPI-
stained image (Fig. 6E and F respectively). Phase-
contrast light microscopy of wet preparations showed that
these grossly abnormal parasites are still viable, with mul-
tiple ﬂagella moving in an uncoordinated fashion with
detached ﬂagella in some instances radiating from the
central body in many directions. There is also consider-
able disruption of the parasite surface with what appears
to be membrane disorganization and deterioration. The
changes highlighted on the surface are probably an indi-
cation of the latter stages of the RNAi effect with cells that
are close to death, as can be seen for the central parasite
in Fig. 6D.
The identity of the electron-dense organelles as gly-
cosomes was veriﬁed by immuno-cytochemistry. TEM
sections of WT, non-induced and induced samples at
72 h were labelled with an antibody to the glycosomal
matrix enzyme marker, T. brucei glyceraldehyde phos-
phate dehydrogenase (GAPDH) and visualized with
10 nm protein-A gold particles (Fig. 7). In the non-
induced samples, gold particles are exclusively localized
to glycosomes conﬁrming the speciﬁcity of the antibody
reagent (Fig. 7A and B). In contrast, the induced
samples show pronounced labelling of glycosomes with
additional gold particles in the cytosol (Fig. 7C and D,
arrows). The matrix of the elongated electron-dense
structure in Fig. 7D is also heavily stained conﬁrming
that the sausage-shaped structures (Fig. 6C) are likely
to be glycosomes.
To verify whether there is an increase in the number of
glycosomes following PTR1 depletion, immunoﬂuores-
cence studies were undertaken using anti-GAPDH. Stain-
ing for GAPDH in the non-induced control is punctate in
nature (Fig. 8A), which is more pronounced and diffuse
following induction with tetracycline at 48 h. Staining
increased to such a level that it covered almost the entire
Fig. 5. PTR1 depletion results in changes to
cell cycle progression. Microscopic analysis of
DAPI stained RNAi cells of non-induced (0 h)
and induced (24, 48 and 72 h) populations
analysed to determine the proportion of
trypanosomes with different numbers of
kinetoplasts (K) and nuclei (N). Percentage
bar chart depicts changes in the K/N content
per cell after tetracycline induction of RNAi.
Approximately 300 parasites per population
were analysed (n = 2,  SD): non-induced
control (black bars); 24 h induction (dark grey
bars); 48 h induction (light grey bars) and
72 h induction (white bars).
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also visible along the long thin structures radiating out
from the main body of these multinucleated and multiki-
netoplast parasites (Fig. 8C). These structures were con-
ﬁrmed to be detached ﬂagella by staining with antibody to
the paraﬂagellar rod protein, ROD1 (Fig. 9). The increase
in glycosomal staining pattern illustrated with GAPDH fol-
lowing RNAi expression was conﬁrmed using an alterna-
tive glycosomal matrix marker, aldolase (ALD). Induction
at 48 h resulted in a partial diffuse staining into the cyto-
plasm; however, unlike GAPDH, no punctuate staining
was visible in the ﬂagella at 72 h.
Subcellular distribution of PTR1 and glycosomal markers
Cytosolic and glycosomal fractions of bloodstream form T.
brucei were prepared by ultracentrifugation, following digi-
tonin treatment of WT and 48 h induced RNAi cells and
Fig. 6. Morphology of PTR1-depleted cells by electron microscopy.
A. TEM section of non-induced controls.
B and C. TEM sections of 72-h induced cells depicting increased number of ﬂagella and glycosomes.
D. SEM images of 72-h induced cells, one with a normal (top left) and abnormal (bottom right) appearance compared with non-induced
control (inset).
E. Equivalent DAPI-stained 72-h induced cell with multiple ﬂagella.
Abbreviations used in TEM sections: nucleus (N); nuclear membrane (NM); basal bodies (BB); kinetoplast (K); ﬂagellar rod (FR); ﬂagellar
pocket (FP); axonemes (Ax and black arrow heads); glycosomes (G); lysosomes (L); paraxial rod (PR); microtubules (MT); acidocalcisomes
(Ac); autophagic vacuoles (AV) internal non-membrane bound ﬂagellum (*). White arrow heads in SEM images highlight ﬂagella. Black and
white bars represent 200 nm.
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© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 658–671Fig. 7. Localization and distribution of GAPDH by immuno-gold labelling. Thin-layer sections were labelled with anti-GAPDH and stained with
protein A gold particles and examined by TEM. WT (A), RNAi non-induced (B) and induced (C–D) at 72 h. Abbreviations used: nucleus (N);
glycosome (G) and white asterisks alongside black dots represent 10 nm gold particles present within glycosomes, while white arrows depict
particles outside glycosomes. Scale bar represents 200 nm.
Fig. 8. The effect of PTR1 depletion on the subcellular distribution of the glycosomal matrix enzyme, GAPDH by immunoﬂuorescence
microscopy. Non-induced (A), induced 48 h (B) and 72 h (C) RNAi cells were labelled with a glycosomal matrix marker, GAPDH (green) with
staining of nuclear and kinetoplast DNA by DAPI (blue). MN, multinucleated, MK, multikinetoplastid. Scale bar represents 10 mm.
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cytosolic and glycosomal markers (Fig. 10). PTR1 was
recovered exclusively in the cytosolic fraction along with
the cytosolic enzyme marker, enolase. Similar results
were obtained for procyclic forms (Fig. S3). Reduced
levels of PTR1 are evident in the cytosolic non-induced
fraction of RNAi cells compared with WT, due to the leaky
nature of p2T7TiTAblue RNAi vector (Alibu et al., 2005).
Following RNAi induction for 48 h, PTR1 is below the limit
of detection, whereas enolase and PEX13, a glycosomal
membrane-bound protein, were unchanged. Densitom-
etry of the band stained for the glycosomal matrix enzyme
GAPDH indicated that the pellet fraction was unchanged
whereas the amount in the cytosol was increased approxi-
mately twofold. Although analysis of 72 h induced
samples was not possible due to lack of material, the
increased amount of GAPDH observed 48 h after induc-
tion, supports the mis-localization of GAPDH to the
cytosol illustrated in the immuno-gold labelling studies at
72 h (Fig. 7).
Discussion
The gene knockout, RNAi knockdown and rescue studies
reported here provide strong evidence that PTR1 is
essential for the blood-stream form of the African
trypanosome. Loss of PTR1 by RNAi is cytocidal rather
than cytostatic, which is a distinct advantage from a drug
discovery perspective. This lethal RNAi phenotype can be
rescued by expression of functionally active L. major
PTR1, or by supplementation with tetrahydrobiopterin.
PTR1 levels were markedly reduced even in the absence
of inducer due to poor regulation of the pLew82 vector.
While this had no discernable effect on growth in rich
medium in vitro, the virulence of the PTR1 RNAi T. brucei
was considerably attenuated in mice. Further loss of viru-
lence was evident when RNAi was induced, but some
mice still succumbed to infection. This is most likely due to
the instability of the RNAi machinery as previously
reported (Chen et al., 2003). However, since supplemen-
tation with 10 mM tetrahydrobiopterin was able to rescue
the trypanocidal effect in vitro, we cannot deﬁnitively
exclude the possibility that the steady-state levels of tet-
rahydrobiopterin present within the animal host plasma
(~0.1 mM) are contributing to survival (Fukushima and
Nixon, 1980; Yoshida et al., 2000). The fact that BH4 is
extremely unstable in culture medium and that repeated
daily addition of BH4 was found to be toxic to T. brucei
could explain the failure to generate a double knockout
line using BH4 as a nutritional rescue. Thus, ultimate proof
Fig. 9. Immunolocalisation of aldolase and paraﬂagellar rod marker, ROD1 in RNAi depleted cells. Co-localization of aldolase (glycosomal
marker, green) and ROD1 (paraﬂagellar rod marker, red) with DAPI (blue) on RNAi cells. Non-induced (A); induced 48 h (B); and 72 h (C)
RNAi cells. MN, multinucleated, MK, multikinetoplastid, and scale bar represents 10 mm.
Fig. 10. The effect of PTR1 depletion on the subcellular
distribution of glycolytic enzymes. Digitonin fractionation of intact
WT and RNAi cells grown for 48 h (in the absence ‘–’ and presence
‘+’ of tetracycline) were incubated with 150 mgm l
-1 of digitonin and
processed as described in Material and Methods. The release of
PTR1, enolase, PEX13 and GAPDH from digitonin-treated cells
was determined in supernatant (S) and pellet (P) fractions by
Western blot.
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chemical validation using potent and speciﬁc drug-like
inhibitors of PTR1 with appropriate pharmacological
properties. Unfortunately, the currently available inhibitors
do not meet these speciﬁcations (Cavazzuti et al., 2008;
Mpamhanga et al., 2009; Shanks et al., 2010). Nonethe-
less, combined inhibition of dihydrofolate reductase and
PTR1 remains an attractive chemotherapeutic strategy
(Hardy et al., 1997; Cavazzuti et al., 2008; Tulloch et al.,
2010).
Our morphological data illustrate that knockdown of
PTR1 results in cells that are unable to divide normally,
although they can still undergo nuclear division and kine-
toplast segregation. Formation of multiﬂagellated para-
sites has also been reported in a number of other RNAi
studies dissecting organelle biogenesis including: deple-
tion of trypanin, a component of the dynein regulatory
complex of the ﬂagellum (Ralston and Hill, 2006); deple-
tion of centrin1, a component associated with the basal
bodies and responsible for segregation of the linked
organelles: ﬂagellum, kinetoplasts and Golgi (Selva-
pandiyan et al., 2007); depletion of the aurora-like kinase
AUK1, a chromosome passenger protein (Li and Wang,
2006; Jetton et al., 2009); and depletion of CAP5.5 result-
ing in defects in microtubule organization (Olego-
Fernandez et al., 2009). However, none of these studies
have observed the glycosomal abnormalities reported
here. Further work is required to determine whether other
RNAi mutants with cytokinesis defects might show similar
glycosomal abnormalities.
Knockdown of PTR1 also affects glycosomal numbers
and their morphology, as judged by TEM. PTR1 knock-
down also causes partial mislocalisation to the cytosol of
the glycosomal matrix enzymes, GAPDH and aldolase, as
seen in the immunoﬂuorescence and digitonin fraction-
ation experiments. In our view, mislocalization could be
due to either defective import into the glycosome or due to
loss of integrity of the glycosomal membrane. However,
similar effects observed in studies on the functional roles
of peroxins have been attributed to defective import. Per-
oxins (PEX) are a large family of peroxisomal proteins
which are involved in glycosomal biogenesis via the
import of newly synthesized proteins from the cytosol
(Parsons et al., 2001). Cellular knockdown by RNA inter-
ference of PEX 13 (Furuya et al., 2002; Verplaetse et al.,
2009), GIM5 (a PEX11-related protein) (Furuya et al.,
2002; Moyersoen et al., 2003; Voncken et al., 2003; Ver-
plaetse et al., 2009), PEX14 (Moyersoen et al., 2003),
PEX19 (Banerjee et al., 2005); and PEX6, PEX10 and
PEX12 (Krazy and Michels, 2006) all resulted in the
partial mislocalization of glycosomal matrix enzymes to
the cytosol. Overexpression of PEX11 led to an increased
number of glycosomes which were elongated and clus-
tered (Lorenz et al., 1998), whereas knockdown of PEX19
resulted in smaller numbers of larger glycosomes (Baner-
jee et al., 2005). However, none of these studies reported
defects in cytokinesis that we observed here.
The discovery that TbPTR1 is present within the
cytosol in bloodstream (Fig. 10) and procyclic forms
(Fig. S3) refutes the predicted glycosomal location for
PTR1, based on the PST1 consensus sequence -VHA at
its C-terminus (Opperdoes and Szikora, 2006). This is
consistent with the failure to detect PTR1 by a proteomic
analysis of puriﬁed T. brucei glycosomes (Vertommen
et al., 2008) and agrees with the cytosolic location of a
GFP-PTR1 chimera in L. donovani (Kumar et al., 2007).
Likewise, both trypanothione reductase and trypan-
othione peroxidase from T. brucei also contain putative
glycosomal targeting sequences, yet the former is clearly
cytosolic (Smith et al., 1991) and the latter is located in
the cytosol and mitochondria (Schlecker et al., 2005).
This underlines the need for experimental veriﬁcation of
any in silico bioinformatic predictions (Wanders and
Waterham, 2006).
PTR1 clearly has pleiotropic effects on cytokinesis,
ﬂagellar morphology and glycosome biogenesis. The
challenging question is what is the underlying biochemical
mechanism? Of the two known functions for PTR1, the
maintenance of biopterin in its tetrahydro-form seems
more likely than the salvage of folate to dihydrofolate,
since the growth phenotype can be rescued by supple-
mentation with H4B in high- or low-folate media containing
thymidine. Since the functions of pterins remain to be
elucidated in T. brucei one can only speculate what these
functions might be. For example, part of the ether lipid
biosynthetic pathway is present in mammalian peroxi-
somes cells (Kaufman et al., 1990) and in trypanosomatid
glycosomes (Lux et al., 2000; Parsons et al., 2001;
Michels et al., 2006). To date, the ﬁrst three enzymes of
this pathway have been identiﬁed in trypanosomatids by
fractionation, bioinformatic and proteomic based analysis
(Heise and Opperdoes, 1997; Opperdoes and Szikora,
2006; Vertommen et al., 2008), but none of these are
known to be pterin-dependent. However, BH4 is involved
in ether lipid catabolism in mammalian cells, where it
serves as an essential cofactor for the cleavage of ether
lipids via glyceryl ether monooxygenase (EC 1.14.16.5)
located in the microsomal compartment (Watschinger
et al., 2009). The ultimate products of ether lipid cleavage
are glycerol and a fatty alcohol. Possibly, these fatty alco-
hols could serve in the subsequent ether lipid synthesis in
the glycosome. However, the fact that oxidative cleavage
of ether lipids in L. donovani was found to be dependent
on NADPH rather than tetrahydrobiopterin (Ma et al.,
1996) tends to argue against this hypothesis. Tetrahydro-
biopterin also plays a role in defence against oxidative
and nitrosative stress in mammalian cells (Mogi et al.,
1999; Ozkor and Quyyumi, 2008) and recent studies in
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similar role for Leishmania spp. (Moreira et al., 2009; Nare
et al., 2009).
In conclusion, our data strongly suggest that PTR1 is
essential for blood stream T. brucei for growth and sur-
vival in vitro and in the animal host. The phenotypic abnor-
malities uncovered in this investigation suggest a
potential role for PTR1 in the biogenesis of the glycosome
and the ﬂagellum. Further studies are underway in our
laboratory to investigate these and other possibilities.
Experimental procedures
Trypanosome culture
Trypanosoma brucei bloodstream form ‘single marker’ S427
(T7RPOL TETR NEO) and transfected cells were cultured as
previously described (Wirtz et al., 1999) and (Alibu et al.,
2005). Folate deﬁcient media (FDM) and growth conditions
used in the study were as previously described (Sienkiewicz
et al., 2008). Tetrahydrobiopterin was purchased from B.
Shircks Laboratories (Jona, Switzerland) and 10 mM stock
was prepared in degassed 0.1 M HCl.
Cloning and generation of transgenic cell lines
All constructs made were sequenced and prepared for elec-
troporation using QIAprep Miniprep Plasmid Kit (Qiagen).
DNA constructs were prepared for electroporation into trypa-
nosomes and cloned with all procedures performed as pre-
viously described (Wirtz et al., 1999; Sienkiewicz et al.,
2008). Primers used in this study to generate the RNAi and
overexpressor constructs (Table S1) are based on the
GeneDB sequences for T. brucei PTR1 (Tb927.8.2210, 927
strain) and L. major PTR1 (LmjF23.0270, Friedlin strain). For
the disruption of PTR1 function, a 403 bp region (nucleotide
position 399–801; http://trypanofan.path.cam.ac.uk/software/
RNAit.html) was directly ligated into the p2T7
TiTAblue vector
(http://trypanofan.path.cam.ac.uk/trypanofan/vector/; a gen-
erous gift from David Horn), linearized by digestion with NotI
and transfected by electroporation to generate RNAi cells
under hygromycin selection (4 mgm l
-1). An overexpressor
construct (pLew82), containing the L. major PTR1 ORF was
also made for generation of an overexpressor WT (
oeWT)
under phleomycin selection (2.5 mgm l
-1). The
oeWT cells gen-
erated were used for the reintroduction of the p2T7
TiTAblue
RNAi construct to generate
oeRNAi cells. All tetracycline
induction experiments were initiated at 1 ¥ 10
4 cells ml
-1 and
tetracycline added daily at 1 mgm l
-1.
DNA analysis
The WT and RNAi genomic DNA(5 mg) was digested with the
restriction enzyme StuI and blots were subsequently probed
with TbPTR1 ORF as described previously (Sienkiewicz
et al., 2008). Southern blot analysis was used to conﬁrm the
successful integration of the selectable gene markers into
WT cells (see Supporting information).
Western blot analysis
The WT, RNAi (0, 24 and 48 h) and
oeRNAi (48 h) cells were
centrifuged at 20 000 g for 5 min at 4°C. The cell pellets
(1 ¥ 10
6 parasites per sample) were resuspended in SDS
Laemmli buffer, boiled for 5 min and micro-centrifuged as
above. The supernatants were then separated by SDS-
PAGE and subsequently transferred onto nitrocellulose for
immunoblotting as previously described (Sienkiewicz et al.,
2008). The immunoblot for the RNAi set was sequentially
probed with polyclonal antisera raised against T. brucei
PTR1 (1:500 dilution) and BiP (1:10 000), in conjunction with
a secondary rabbit anti-rat HRP-conjugated antibody
(1:5 000, Dako). The
oeRNAi samples were sequentially
probed with T. brucei PTR1 antisera and L. major PTR1
(1:10 000), in conjunction with secondary rabbit anti-rat and
goat anti-rabbit HRP-conjugated antibodies (1:5000 and
1:10 000 respectively) and the immunoblots visualized with
the ECL plus (enhanced chemiluminescence) system from
GE Healthcare.
Enzyme assays
Lysates of T. brucei were prepared as previously described
(Vickers and Fairlamb, 2004). To ensure adequate extraction
of parasites, trypanothione reductase activity was measured
in clariﬁed lysates as previously described (Jockers-Scherubl
et al., 1989).Assays for PTR1 activity in clariﬁed lysates were
carried out at 22°C in 50 mM HEPES (pH 7.4), containing
0.1% (v/v) triton X-100, adjusted to an ionic strength of
100 mM with KCl. Lysates were preincubated with 100 mM
NADPH cofactor for 2 min and reactions were initiated by the
addition of 25 nM H2B, in a ﬁnal volume of 200 ml. Enzymatic
reactions were further incubated for 1 min, before aliquots
(100 ml) were removed and oxidized with iodine under alka-
line conditions and analysed by HPLC as previously
described (Shanks et al., 2010). Protein was measured using
Coomassie blue using bovine serum albumin as standard
(Bradford, 1976).
Morphological analysis
RNAi cells (grown in the presence and absence of tetracy-
cline) were ﬁxed with methanol or 4% (v/v) paraformaldehyde
and stained with either Giemsa or 4′,6-diamidino-2-
phenylindole (Slowfade Gold antifade reagent with DAPI,
Invitrogen). Images were captured on a Zeiss Axiovert 200 M
ﬂuorescence and light microscope using Zeiss AxioVision
Software. Approximately 300 parasites per population were
assessed for changes in N:K ratio and data presented as the
mean of two independent knockdown experiments. For elec-
tron microscopy, cells were ﬁxed for 24 h in 2% (v/v) glutaral-
dehyde and 4% (v/v) paraformaldehyde in 0.2 M PIPES, pH
7.2 and prepared for both SEM and TEM as previously
described (Sienkiewicz et al., 2008).
Immuno-gold labelling of TEM sections
For immunoelectron microscopy the labelling and staining
procedure was carried out as essentially described (Sandi-
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previously embedded in Durcupan resin were etched with 1%
(v/v) periodic acid and the osmium removed by 2% (w/v)
sodium periodate. The sections were then probed with anti-
GAPDH (1: 50 dilution) antibody and subsequently incubated
with Protein A labelled with 10 nm gold particles (1:50 dilu-
tion, BB International) to visualize the primary antibody. The
sections were stained with 3% (v/v) aqueous uranyl acetate
and Reynold’s lead citrate prior to examination with a JEOl-
1200 EX TEM.
Immunoﬂuorescence
Cells were ﬁxed with 4% (v/v) paraformaldehyde onto poly-
L-lysine coated chamber slides and probed with antisera
raised against T. brucei GAPDH (rabbit antiserum, 1:2500),
ALD (rabbit antiserum, 1:6000) and ROD1 (monoclonal anti-
serum, neat), generous gifts from Paul Michels and Keith
Gull, as previously described (Woods et al., 1989; Verplaetse
et al., 2009). Combination of secondary Alexaﬂuor 488 and
555 conjugated ant-rabbit or anti-mouse immunoglobulins
were used (both 1:800 dilution, Molecular Probes) and slides
were counter-stained with DAPI prior to analysis. Images
were captured using FITC, Texas Red and DAPI ﬁlters as
previously described. Property parameters were set on the
AxioVision microscope software to optimize the intensity of
the ﬂuorescent stains standardized against the non-induced
controls and these values were retained for all images
captured. Images shown are representative of three indepen-
dent experiments.
Separation of cytosolic and glycosomal rich proteins by
digitonin permeabilization
Digitonin permeabilization experiments were undertaken to
separate cytosolic and glycosomal rich proteins from WT and
RNAi cells (grown in the absence and presence of tetracy-
cline for 48 h), as previously described (Voncken et al.,
2003). Brieﬂy, live cells were washed once in STEN (250 mM
sucrose, 25 mM Tri-HCl, 1 mM EDTA, 150 mM NaCl, pH 7.4),
pelleted and resuspended in STEN containing 150 mgm l
-1
digitonin (at a ﬁnal concentration 5 ¥ 10
8 cells ml
-1) which was
subsequently incubated for 1 h on ice. The digitonin treated
cells were then fractionated by centrifugation (2 min,
20 000 g, at 4°C) resulting in an enriched cytosolic (s, super-
natant) and glycosomal (p, pellet) fractions. Approximately
5 ¥ 10
6 fractionated parasites were processed for Western
blot analysis and sequentially probed with the following anti-
bodies raised against T. brucei PTR1 (1:500), rabbit antisera
raised against PEX13 (1:20 000), enolase (1:100 000) and
GAPDH (1:100 000). Blots were subsequently incubated with
secondary anti-rat (1:5000 dilution) and anti-rabbit HRP-
conjugated antiserum (1:15 000) and visualized as previously
described.
In vivo studies
All cell lines (WT, RNAi,
oeRNAi) were cultured for 24 h in the
absence of selectable drugs before female National Medical
Research Institute (NMRI) mice (5 per group) were infected
with a single intraperitoneal injection of 10
5 parasites in 0.2 ml
glucose saline as previously described (Sienkiewicz et al.,
2008). For the RNAi and
oeRNAi cells, a single inoculum of
non-induced cells were infected into two sets of mice with one
group being given 2.5 mgm l
-1 doxycycline in their drinking
water (starting a week prior to infection and continuing
throughout the 30 day period).Animals were fed ad libitum on
standard chow (Diet 3, SAS, Edinburgh). Parasitaemia levels
were monitored throughout the 30 day experiment (Sienk-
iewicz et al., 2008). All animal experiments undertaken were
carried out following local ethical review and under UK regu-
latory licensing in accordance with the European Communi-
ties Council Directive (86/609/EEC).
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